450 related articles for article (PubMed ID: 29593729)
21. Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases.
Booth DR; Ding N; Parnell GP; Shahijanian F; Coulter S; Schibeci SD; Atkins AR; Stewart GJ; Evans RM; Downes M; Liddle C
Genes Immun; 2016 Jun; 17(4):213-9. PubMed ID: 26986782
[TBL] [Abstract][Full Text] [Related]
22. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
Cox MB; Ban M; Bowden NA; Baker A; Scott RJ; Lechner-Scott J
Mult Scler; 2012 Jan; 18(1):16-22. PubMed ID: 21816760
[TBL] [Abstract][Full Text] [Related]
23. FokI vitamin D receptor gene polymorphism in association with multiple sclerosis risk and disability progression in Slovaks.
Čierny D; Michalik J; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2015 Apr; 37(4):301-8. PubMed ID: 25376135
[TBL] [Abstract][Full Text] [Related]
24. Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease.
Gallone G; Haerty W; Disanto G; Ramagopalan SV; Ponting CP; Berlanga-Taylor AJ
Hum Mol Genet; 2017 Jun; 26(11):2164-2176. PubMed ID: 28335003
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.
Orton SM; Ramagopalan SV; Para AE; Lincoln MR; Handunnetthi L; Chao MJ; Morahan J; Morrison KM; Sadovnick AD; Ebers GC
J Neurol Sci; 2011 Jun; 305(1-2):116-20. PubMed ID: 21440908
[TBL] [Abstract][Full Text] [Related]
26. The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
Al-Temaimi RA; Al-Enezi A; Al-Serri A; Alroughani R; Al-Mulla F
PLoS One; 2015; 10(11):e0142265. PubMed ID: 26540116
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
Agnello L; Scazzone C; Ragonese P; Salemi G; Lo Sasso B; Schillaci R; Musso G; Bellia C; Ciaccio M
Neurol Sci; 2016 Feb; 37(2):261-7. PubMed ID: 26506927
[TBL] [Abstract][Full Text] [Related]
28. ε
Gezmis H; Mayda Domac F; Ormeci B; Uyanik H; Doran T; Keles EC; Kirac D
Int J Clin Pract; 2021 Nov; 75(11):e14801. PubMed ID: 34486787
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D and its immunoregulatory role in multiple sclerosis.
Niino M
Drugs Today (Barc); 2010 Apr; 46(4):279-90. PubMed ID: 20502725
[TBL] [Abstract][Full Text] [Related]
30. Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.
Abdollahzadeh R; Fard MS; Rahmani F; Moloudi K; Kalani BS; Azarnezhad A
J Neurol Sci; 2016 Aug; 367():148-51. PubMed ID: 27423580
[TBL] [Abstract][Full Text] [Related]
31. ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks.
Čierny D; Michalik J; Škereňová M; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2016 Aug; 38(8):678-84. PubMed ID: 27338176
[TBL] [Abstract][Full Text] [Related]
32. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.
Smolders J; Damoiseaux J; Menheere P; Tervaert JW; Hupperts R
J Neuroimmunol; 2009 Feb; 207(1-2):117-21. PubMed ID: 19178954
[TBL] [Abstract][Full Text] [Related]
33. Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.
Krizova L; Kollar B; Jezova D; Turcani P
Gen Physiol Biophys; 2013 Dec; 32(4):459-66. PubMed ID: 24067280
[TBL] [Abstract][Full Text] [Related]
34. Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.
Singh PK; van den Berg PR; Long MD; Vreugdenhil A; Grieshober L; Ochs-Balcom HM; Wang J; Delcambre S; Heikkinen S; Carlberg C; Campbell MJ; Sucheston-Campbell LE
BMC Genomics; 2017 Feb; 18(1):132. PubMed ID: 28166722
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.
Niino M; Miyazaki Y
Can J Physiol Pharmacol; 2015 May; 93(5):319-25. PubMed ID: 25798693
[TBL] [Abstract][Full Text] [Related]
36. Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma.
Lin Y; Chahal HS; Wu W; Cho HG; Ransohoff KJ; Dai H; Tang JY; Sarin KY; Han J
Int J Cancer; 2017 May; 140(9):2085-2091. PubMed ID: 28177523
[TBL] [Abstract][Full Text] [Related]
37. Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis.
Cancela Díez B; Pérez-Ramírez C; Maldonado-Montoro MDM; Carrasco-Campos MI; Sánchez Martín A; Pineda Lancheros LE; Martínez-Martínez F; Calleja-Hernández MÁ; Ramírez-Tortosa MC; Jiménez-Morales A
Pharmacogenet Genomics; 2021 Feb; 31(2):40-47. PubMed ID: 33044390
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in the Azeri Population of Iran.
Pourostadi M; Sattarpour S; Poor BM; Asgharzadeh M; Kafil HS; Farhoudi M; Asgharzadeh V; Vegari A; Najafi-Ghalelou N; Rashedi J
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1306-1311. PubMed ID: 32914731
[TBL] [Abstract][Full Text] [Related]
39. Role of gene polymorphisms in vitamin D metabolism and in multiple sclerosis.
Elkama A; Karahalil B
Arh Hig Rada Toksikol; 2018 Mar; 69(1):25-31. PubMed ID: 29604195
[TBL] [Abstract][Full Text] [Related]
40. The association between vitamin D receptor polymorphisms and multiple sclerosis in a Turkish population.
Kamisli O; Acar C; Sozen M; Tecellioglu M; Yücel FE; Vaizoglu D; Özcan C
Mult Scler Relat Disord; 2018 Feb; 20():78-81. PubMed ID: 29331875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
